EUVIMEDEUVIMED entdecken
Crossref

12-PUB: Screening for Peripheral Arterial Disease in Diabetes Using the Ankle-Brachial Index

JERUSHA OWUSU-BARNIE, RICARDO LUNDI, FRANCES LOGAN, JOSEPH ERARDI, BETH A. WELLS, JESSICA REIS, RUTH WEINSTOCK

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-12-pub ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von JERUSHA OWUSU-BARNIE und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Noninvasive arterial screening is recommended for adults with diabetes age ≥50 years or with any signs of Peripheral Arterial Disease (PAD) at any age. Ankle Brachial Index (ABI) was used to screen adults ≥50 years of age in a Podiatry clinic embedded in an adult diabetes center.

Methods

Adults ages ≥50 years seen by podiatry were offered ABI testing over 13 months (10/2024-11/2025). Data collected from the EMR included demographics, BMI, diabetes type and date of diagnosis, HbA1c, smoking history, ABI results and referrals to vascular surgery.

Results

Of 980 eligible adults seen, 360 (36.7%) were screened, 235 (24.0%) were excluded (inadequate cuff size (n=87), pain/edema/unable to lay flat (n=37), known vascular disease(n=70), wheelchair-bound (n=2), shunt/fistula present (n=12), plastic allergy (n=1), device malfunction (n=5), wound present (n=9), amputation(n=6), late to appointment (n=6)). Of those screened 118 (32.8%) had abnormal ABI results, of whom 40 (11.1%) had evidence of PAD and 78 (21.7%) had results that were indeterminate. Of the 77 evaluated by vascular surgery, 20 (26.0%) were found to have PAD. PAD (vs. no PAD) was more common in those with longer duration of diabetes (mean: 27 vs. 22 years), older age (mean: 73 vs. 72 years) and tobacco use (70.0% (14) vs. 50.9% (29)).

Conclusion

Screening for PAD in adults with diabetes ≥50 years of age in a podiatry clinic using ABI testing resulted in evidence for PAD in 11.1% of those screened; 21.7% had indeterminate results. The cost-effectiveness of this approach requires further study. Disclosure J. Owusu-Barnie: None. R. Lundi: None. F. Logan: None. J. Erardi: None. B.A. Wells: None. J. Reis: None. R. Weinstock: Research Support; Current; Amgen Inc., Eli Lilly and Company, JDRF, Diasome, DEKA Research and Development, Tandem Diabetes Care, Inc. Research Support; Ended; Kowa Research Institute, Inc. Research Support; Current; National Institutes of Health. Research Support; Ended; Insulet Corporation. Research Support; Current; T1D Exchange.

Zitieren

APA

OWUSU-BARNIE, J., LUNDI, R., LOGAN, F., ERARDI, J., WELLS, B. A., REIS, J., & WEINSTOCK, R. (2026). 12-PUB: Screening for Peripheral Arterial Disease in Diabetes Using the Ankle-Brachial Index. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-12-pub

Vancouver

OWUSU-BARNIE J, LUNDI R, LOGAN F, ERARDI J, WELLS BA, REIS J, et al. 12-PUB: Screening for Peripheral Arterial Disease in Diabetes Using the Ankle-Brachial Index. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-12-pub

BibTeX
@article{OWUSUBARNIE2026,
  author = {OWUSU-BARNIE, JERUSHA and LUNDI, RICARDO and LOGAN, FRANCES and ERARDI, JOSEPH and WELLS, BETH A. and REIS, JESSICA and WEINSTOCK, RUTH},
  title = {12-PUB: Screening for Peripheral Arterial Disease in Diabetes Using the Ankle-Brachial Index},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-12-pub}
}
Kostenlos starten →